Central non-glucocorticoid inhibitors of the hypothalamo-pituitary- adrenal axis

Journal of Endocrinology

Volumn 160, Issue 2, 1999, Pages 169-180

  Jessop, D S ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ADRENOMEDULLIN; BETA ENDORPHIN; CARBON MONOXIDE; CORTICOTROPIN; ENDOTHELIN 1; LEPTIN; LIPOCORTIN 1; NITRIC OXIDE; OXYTOCIN; PROTIRELIN; SOMATOSTATIN; SUBSTANCE P; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ATRIAL NATRIURETIC FACTOR; ENDOTHELIN; PEPTIDE; PREPRO THYROTROPIN RELEASING HORMONE; PREPRO-THYROTROPIN-RELEASING HORMONE; PROTEIN; PROTEIN PRECURSOR;

CORTICOTROPIN RELEASE; FEEDBACK SYSTEM; HORMONAL REGULATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STRESS; THALAMUS MIDLINE NUCLEUS; DRUG ANTAGONISM; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MENTAL STRESS; PHYSIOLOGY;

ADRENOCORTICOTROPIC HORMONE; ADRENOMEDULLIN; ANNEXIN A1; ATRIAL NATRIURETIC FACTOR; BETA-ENDORPHIN; CARBON MONOXIDE; ENDOTHELINS; GAMMA-AMINOBUTYRIC ACID; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LEPTIN; NEUROTRANSMITTER AGENTS; NITRIC OXIDE; OXYTOCIN; PEPTIDES; PITUITARY-ADRENAL SYSTEM; PROTEIN PRECURSORS; PROTEINS; SOMATOSTATIN; STRESS, PSYCHOLOGICAL; SUBSTANCE P; THYROTROPIN-RELEASING HORMONE;

EID: 0033071538     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1600169     Document Type: Review

References (139)

1. Alexander SL & Irvine CH 1995 The effect of naloxone administration on the secretion of corticotropin-releasing hormone, arginine vasopressin, and adrenocorticotropin in unperturbed horses. Endocrinology 136 5139-5147.
2. Ambrosi B, Bochicchio D, Fadin C, Colombo P & Faglia G 1990 Failure of somatostatin and octreotide to acutely affect the hypothalamo-pituitary-adrenal function in patients with corticotropin hypersecretion. Journal of Endocrinological Investigation 13 257-261.
3. Ambrosi B, Sala C, Bochicchio D, Colombo P, Gazzano G, Fadin C, Morganti A & Faglia G 1994 Effect of atrial natriuretic factor infusion on basal and CRH-stimulated ACTH, cortisol and aldosterone levels in patients with Cushing's or Addison's disease. Clinical Endocrinology 40 589-594.
4. Antoni FA & Dayanithi G 1989 Guanosine 3′:5′ cyclic monophosphate and activators of guanylate cyclase inhibit secretagogue-induced corticotropin release by rat anterior pituitary cells. Biochemical and Biophysical Research Communications 158 824-830.
5. Antoni FA & Dayanithi G 1990 Secretion of ACTH by perifused isolated rat anterior pituitary cells: pulses of secretagogue enhance the secretory response and modify the effect of atriopeptin. Journal of Endocrinology 125 365-373.
6. Bierwolf C, Burgemeister A, Lüthke K, Born J & Fehin HL 1998 Influence of exogenous atrial natriuretic peptide on the pituitary-adrenal response to corticotropin-releasing hormone and vasopressin in healthy men. Journal of Endocrinology and Metabolism 83 1151-1157.
7. Bowman ME, Robinson PJ & Smith R 1997 Atrial natriuretic peptide, cyclic GMP analogues and modulation of guanylyl cyclase do not alter stimulated POMC peptide release from perifused rat or sheep corticotrophs. Journal of Neuroendocrinology 9 929-936.
8. Boyle LL, Brownfield MS, Lent SJ, Goodman B, Vo-Hill H, Litwin J & Carnes M 1997 Intensive venous sampling of adrenocorticotropic hormone in rats with sham or paraventricular lesions. Journal of Endocrinology 153 159-167.
9. Brunetti L, Preziosi P, Ragazzoni E & Vacca M 1993 Involvement of nitric oxide in basal and interleukin-1 beta-induced CRH and ACTH release in vitro. Life Sciences 53 PL219-PL222.
10. Buckingham JC & Cooper TA 1986 Effects of naloxone on hypothalamo-pituitary adrenocortical activity in the rat. Neuroendocrinology 42 421-426.
11. Buckingham JC, Cowell, A-M, Gillies GE, Herbison AE & Steel JH 1997 The neuroendocrine system: anatomy, physiology and responses to stress. In Stress, Stress Hormones and the Immune System, pp 9-47. Eds JC Buckingham, A-M Cowell & GE Gillies, Chichester: John Wiley and Sons.
12. Calogero AE, Gallucca WT, Chrousos GP & Gold PW 1988a Interaction between GABAergic neurotransmission and rat hypothalamic corticotropin releasing honnone secretion in vitro. Brain Research 463 28-36.
13. Calogero AE, Gallucci WT, Gold PW & Chrousos GP 1988b Multiple feedback regulatory loops upon rat hypothalamic corticotropin releasing hormone secretion. Journal of Clinical Investigation 82 767-774.
14. Calogero AE, Raiti F, Nicolosi G, Burrello N, D'Agata R & Mantero F 1994 Effects of endothelin-1 and endothelin-3 on rat hypothalamic corticotrophin-releasing hormone and pituitary ACTH release in vitro. Journal of Endocrinology 140 419-424.
15. Cataldi M, Magnan E, Guillaume V, Dutour A, Sauze N, Mazzocchi L, Conte-Devolx B & Oliver C 1994 Acute stress stimulates secretion ot GHRH and somatostatin into hypophysial portal blood of sheep. Neuroscience Letters 178 103-106.
16. Charles CJ, Espiner EA, Richards AM & Donald RA 1995 Central C-type natriuretic peptide augments the hormone response to hemorrhage in conscious sheep. Peptides 16 129-132.
17. Charles CJ, Rademaker MT, Richards AM, Cooper GJ, Coy DH & Nicholls MG 1998 Hemodynamic, hormonal and renal effects of intracerebroventricular adrenomedullin in conscious sheep. Endocrinology 139 1746-1751.
18. Chowdrey HS, Jessop DS & Lightman SL 1990 Substance P stimulates arginine vasopressin and inhibits adrenocorticotropin release in vivo in the rat. Neuroendocrinology 52 90-93.
19. Chowdrey HS, Jessop DS, Patel H & Lightman SL 1991 Altered adrenocorticotropin, corticosterone and oxytocin responses to stress during chronic salt load. Neuroendocrinology 54 635-638.
20. Chowdrey HS, Larsen PJ, Harbuz MS, Lightman SL & Jessop DS 1995 Endogenous substance P inhibits the expression of CRH during a chronic inflammatory stress. Life Sciences 57 2021-2029.
21. Christian HC, Taylor AD, Flower RJ, Morris JF & Buckingham JC 1997 Characterization and localization of lipocortin 1-binding sites on rat anterior pituitary cells by fluorescence-activated cell analysis/ sorting and electron microscopy. Endocrinology 138 5341-5351.
22. Clarke I, Jessop D, Millar R, Morris M, Bloom S, Lightman S, Coen C, Lew R & Smith A 1993 Many peptides that are present in the external zone of the median eminence are not secreted into the hypophysial portal blood of sheep. Neuroendocrinology 57 765-775.
23. Costa A, Trainer P, Besser M & Grossman A 1993 Nitric oxide modulates the release of corticotrophin-releasing hormone from the rat hypothalamus in vitro. Brain Research 605 187-192.
24. Costa A, Ponta A, Martignoni E, Nappi G & Grossman A 1997 Stimulation of corticotrophin-releasing hormone release by the obese (ob) gene product, leptin, from hypothalamic explants. Neuroreport 8 1131-1134.
25. Culman J, Itoi K & Unger T 1995 Hypothalamic tachykinins: mediators of stress responses? Annals of the New York Academy of Sciences 771 204-218.
26. Dallman MF, Akana SF, Scribner KA, Bradbury MJ, Walker C-D, Stark AM & Cascio CS 1992 Stress, feedback and facilitation in the hypothalamo-pituitary-adrenal axis. Journal of Neuroendocrinology 4 517-526.
27. Darlington DN, Neves RB, Ha T, Chew G & Dallman MF 1990 Fed, but not fasted, adrenalectomised rats survive the stress of hemorrhage and hypovolemia. Endocrinology 127 759-765.
28. De Kloet ER, Vreugdenhil E, Oitzl MS & Joels M 1998 Brain corticosteroid receptor balance in health and disease. Endocrine Reviews 19 269-301.
29. Delitala G, Trainer PJ, Oliva O, Fanciulli G & Grossman AB 1994 Opioid peptide and α-adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man. Journal of Endocrinology 141 163-168.
30. van Dijk G, Donahey JC, Thiele TE, Scheurink AJ, Steffens AB, Wilkinson CW, Tenenbaum R, Campfield LA, Burn P, Seeley RJ & Woods SC 1997 Central leptin stimulates corticosterone secretion at the onset of the dark phase. Diabetes 46 1911-1914.
31. Eckstein N, Wehrenberg W, Louis K, Carmel P, Zimmerman E, Frantz A & Ferin M 1980 Effects of substance P on anterior pituitary secretion in the female rhesus monkey. Neuroendocrinology 31 338-342.
32. Ehrhart-Bornstein M, Hinson JP, Bornstein SR, Scherbaum WA & Vinson GP 1998 Intraadrenal interactions in the regulation of adrenocortical steroidogenesis. Endocrine Reviews 19 101-143.
33. Engler D, Pham T, Fullerton MJ, Funder JW & Clarke IJ 1988 Studies of the regulation of the hypothalamic-pituitary-adrenal axis in sheep with a hypothalamic-pituitary disconnection. Neuroendocrinology 48 551-560.
34. Engler D, Liu J, Clarke IJ & Funder JW 1994 Corticotropin release inhibitory factor. Trends in Endocrinology and Metabolism 5 272-283.
35. Farra M, Navarra P, Tsagarakis S, Besser GM & Grossman A 1991 Inhibition of CRF-41 release by substance P, but not substance K, from the rat hypothalamus in vitro. Brain Research 538 76-78.
36. Fink G, Dow RC, Casley D, Johnston CI, Lim AT, Copolov DL, Bennie J, Carroll S & Dick H 1991 Atrial natriuretic peptide is a physiological inhibitor of ACTH release: evidence from immunoneutralization in vivo. Journal of Endocrinology 131 R9-R12.
37. Franci CR, Anselmo-Franci JA & McCann SM 1992 The role of endogenous natriuretic peptide in resting and stress-induced release of corticotropin, prolactin, growth hormone, and thyroid-stimulating hormone. Proceedings of the National Academy of Sciences of the USA 89 11391-11395.
38. Grandclement B, Brisson C, Bayard F, Tremblay J, Cossard F & Morel G 1995 Localization of mRNA coding for the three subtypes of atrial natriuretic factor (ANF) receptors in rat anterior pituitary gland cells. Journal of Neuroendocrinology 12 939-948.
39. Grossman A & Besser GM 1982 Opiates control ACTH through a noradrenergic mechanism. Clinical Endocrinology 17 287-290.
40. Grossman A & Tsagarakis S 1989 The hunt for the CIA: factors which demonstrate corticotrophin-inhibitory activity. Journal of Endocrinology 123 169-172.
41. Grossman AB, Rossmanith WG, Kabigting EB, Cadd G, Clifton D & Steiner RA 1994 The distribution of hypothalamic nitric oxide synthase mRNA in relation to gonadotrophin-releasing hormone neurons. Journal of Endocrinology 140 R5-R8.
42. Grossman A, Costa A, Forsling M, Jacobs R, Kostoglou-Athanassiou I, Nappi G, Navarra P & Satta MA 1997 Gaseous neurotransmitters in the hypothalamus. The roles of nitric oxide and carbon monoxide in neuroendocrinology. Hormones and Metabolic Research 29 477-182.
43. Harbuz MS, Conde GL, Marti O, Lightman SL & Jessop DS 1997 The hypothalamic-pituitary-adrenal axis in autuimmunity. Annals of the New York Academy of Sciences 823 214-224.
44. Harbuz MS, Marti O, Lightman SL & Jessop DS 1998 Alteration of central serotomn modifies onset and severity of inflammatory arthritis. British Journal of Rheumatology 37 1077-1083.
45. Hausler A, Monnet G & Peter O 1993 Involvement of GABAB receptors in the regulation of the hypothalamo-pituitary-adrenocortical (HPA) axis in rats. Journal of Steroid Biochemistry and Molecular Biology 46 767-771.
46. Heiman ML, Ahima RS, Craft LS, Schoner B, Stephens TW & Flier JS 1997 Leptin inhibition of the hypothalamic-pituitary-adrenal axis in response to stress. Endocrinology 138 3859-3863.
47. de Herder WW & Lamberts SW 1996 Is there a role for somatostatin and its analogs in Cushing's syndrome? Metabolism 45 (Suppl 1) 83-85.
48. Herman JP & Cullinan WE 1997 Neurocircuitry of stress: central control of the hypothalamic-pituitary-adrenocortical axis. Trends in Neurosciences 20 78-84.
49. Hökfelt T, Pernow B, Nilsson G, Wetterburg L, Goldstein M & Jeffcoate S 1978 Dense plexus of substance P immunoreactive nerve terminals in eminentia terminals of the primate hypothalamus. Proceedings of the National Academy of Sciences of the USA 75 1013-1015.
50. Huang Q, Rivest R & Richard D 1998 Effects of leptin on corticotropin-releasing factor synthesis and CRF neuron activation in the paraventricular hypothalamic nucleus of obese (ob/ob) mice. Endocrinology 139 1521-1532.
51. Ibanez-Santos J, Tsagarakis S, Rees LH, Besser GM & Grossman A 1990 Atrial natriuretic peptides inhibit the release of corticotrophin-releasing factor-41 from the rat hypothalamus in vitro. Journal of Endocrinology 126 223-228.
52. Inder WJ, Livesey JH, Ellis MJ, Evans MJ & Donald RA 1996 The effect of beta-endorphin on basal and insulin-hypoglycaemia stimulated levels of hypothalamic-pituitary-adrenal axis hormones in normal human subjects. Clinical Endocrinology 44 7-13.
53. Invitti C, Pecori Girardi F, Dubini A, Piolini M & Cavagnini F 1991 Effect of somatostatin on CRF-stimulated secretion of ACTH, beta-lipotropin and beta-endorphin. Hormone and Metabolic Research 23 233-235.
54. Jessop DS, Chowdrey HS & Lightman SL 1990 Inhibition of rat corticotropin-releasing factor and adrenocorticotropin secretion by an osmotic stimulus. Brain Research 523 1-1.
55. Jessop DS, Chowdrey HS, Larsen PJ & Lightman SL 1992 Substance P: multifunctional peptide in the hypothalamo-pituitary system? Journal of Endocrinology 132 331-337.
56. Jessop DS, Renshaw D, Larsen PJ, Chowdrey HS & Harbuz MS 1998 Endogenous substance P acts centrally to terminate the HPA axis response to acute stress. Abstract P1-410, 80th Annual Meeting, Endocrine Scxiety, New Orleans, USA.
57. Jezova D, Guillaume V, Jurankova E, Carayon P & Oliver C 1994 Studies on the physiological role of ANF in ACTH regulation. Endocrine Regulation 28 163-169.
58. Karanth S, Lyson K & McCann SM 1993 Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami. Proceedings of the National Academy of Sciences of the USA 90 3383-3387.
59. Keim SR & Shekhar A 1996 The effects of GABA A receptor blockade in the dorsomedial hypothalamic nucleus on corticotrophin (ACTH) and corticosterone secretion in male rats. Brain Research 739 46-51.
60. Kellner M, Herzog L, Holsboer F & Wiedemann K 1995 Circadian changes in the sensitivity of the corticotropin-releasing hormone-stimulated HPA system after arginine vasopressin and atrial natriuretic hormone in human male controls. Psychoneuroendocrinology 20 515-524.
61. Kellner M, Diehl I, Knaudt K, Schule C, Jahn H & Wiedemann K 1997 C-type natriuretic peptide exerts stimulatory effects on the corticotropin-releasing hormone-stimulated secretion of hormones in normal man. European Journal of Endocrinology 136 388-393.
62. Kim KC & Rivier C 1998 Influence of nitric oxide synthase inhibitors on the ACTH and cytokine responses to peripheral immune signals. Journal of Neuroendocrinology 10 353-362.
63. Kiss J, Cassell M & Palkovits M 1984 Analysis of the ACTH/β-End/ α-MSH-immunoreactive afferent input to the hypothalamic paraventricular nucleus of the rat. Brain Research 324 91-99.
64. Kostoglou-Athanassiou I, Costa A, Navarra P, Nappi G, Forsling ML & Grossman AB 1998 Endotoxin stimulates an endogenous pathway regulating corticotrophin-releasing hormone and vasopressin release involving the generation of nitric oxide and carbon monoxide. Journal of Neuroimmunology 86 104-109.
65. Kovacs KJ & Elenkov IJ 1995 Differential dependence of ACTH secretion induced by various cytokines on the integrity of the paraventricular nucleus. Journal of Neuroendocrinology 7 15-23.
66. Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, Reines SA, Guanahan L, Snavely D, Wyatt-Knowles E et al. 1998 Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281 1640-1645.
67. Lambens SW, Zuyderwijk J, den Holder F, van Koetsveld P & Hofland L 1989 Studies on the conditions determining the inhibitory effect of somatostatin on adrenocorticotropin, prolactin and thyrotropin release by cultured rat pituitary cells. Neuroendocrinology 50 44-50.
68. Larsen P 1992 Distribution of substance P-immunoreactive elements in the preoptic area and the hypothalamus of the rat. Journal of Comparative Neurology 316 287-313.
69. Larsen P, Jessop D, Patel H, Lightman SL & Chowdrey H 1993 Substance P inhibits the release of anterior pituitary adrenocorticotrophin via a central mechanism involving corticotrophin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus. Journal of Neuroendocrinology 5 99-105.
70. Lee S & Rivier C 1998 Interaction between corticotrophin-releasing factor and nitric oxide in mediating the response of the rat hypothalamus to immune and non-immune stimuli. Molecular Brain Research 57 54-62.
71. Levine JD, Fields HL & Basbaum AI 1993 Peptides and the primary afferent nociceptor. Journal of Neuroscience 13 2273-2286.
72. Lightman SL & Young WS III 1989 Lactation inhibits stress-mediated secretion of corticosterone and oxytocin and hypothalamic accumulation of corticotropin-releasing factor and enkephalin messenger ribonucleic acids. Endocrinology 124 2358-2364.
73. Lim A, Sheward W, Copolov D, Windmill D & Fink G 1990 Atrial natriuretic factor is released into hypophysial portal blood: direct evidence that atrial natriuretic factor may be a neurohormone involved in hypothalamic pituitary control. Journal of Neuroendocrinology 2 15-18.
74. Lim AT, Dow, RC, Yang Z & Fink G 1994 ANP(5-28) is the major molecular species in hypophysial portal blood of the rat. Peptides 15 1557-1559.
75. Link H, Dayanithi G & Gratzl M 1993 Glucocorticoids rapidly inhibit oxytocin-stimulated adrenocorticotropin release from rat anterior pituitary cells, without modifying intracellular calcium transients. Endocrinology 132 873-878.
76. Liposits Zs, Phelix C & Paull W 1987 Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesising neurons in the hypothalamic paraventricular nucleus of the rat. Histochemistry 86 541-549.
77. Liposits Zs, Sievers L & Paull W 1988 NPY and ACTH-immunoreactive innervation of corticotropin releasing factor (CRF)-synthesising neurons in the hypothalamus of the rat. Histochemistry 88 227-234.
78. Loxley HD, Cowell A-M, Flower RJ & Buckingham JC 1993a Effects of lipocortin I and dexamethasone on the secretion of corticotrophin-releasing factors in the rat: in vitro and in vivo studies. Journal of Neuroendocrinology 5 51-61.
79. Loxley HD, Cowell A-M, Flower RJ & Buckingham JC 1993b Modulation of the hypothalamo-pituitary adrenocortical responses to cytokines in the rat by lipocortin 1 and glucocorticoids: a role for lipocortin 1 in the feedback inhibition of CRF-41 release? Neuroendocrinology 57 801-814.
80. McGivern RF, Rittenhouse P, Aird F, Van de Kar LD & Redei E 1997 Inhibition of stress-induced neuroendocrine and behavioural responses in the rat by prepro-thyrotropin-releasing hormone 178-199. Journal of Neuroscience 17 4886-4894.
81. Makara G & Stark E 1974 Effect of γ-ABA and γ-ABA antagonistic drugs on ACTH release. Neuroendocrinology 16 178-190.
82. Malendowicz LK, Nussdorfer GG, Meneghelli V, Nowak M, Markowska A & Majchrzak M 1997 Effects of endothelin-1 on the rat pituitary-adrenocortical axis under basal and stressful conditions. Endocrine Research 23 349-364.
83. Meister B, Hökfelt T, Geffard M & Oertel W 1988 Glutamic acid decarboxylase and γ-aminobutyric acid-like immunoreactivities in corticotropin-releasing factor-containing parvocellular neurons of the hypothalamic paraventricular nucleus. Neuroendocrinology 48 516-526.
84. Milenkovic L & McCann SM 1992 Effect of thymosin alpha 1 on pituitary hormone release. Neuroendocrinology 55 14-19.
85. Milenkovic L, Lyson K, Aguila MC & McCann SM 1992 Effect of thymosin alpha 1 on hypothalamic hormone release. Neuroendocrinology 56 674-679.
86. Mulligan RS, Livesey JH, Evans MJ, Ellis MJ & Donald RA 1997 Atrial natriuretic peptide and C-type natriuretic peptide do not acutely inhibit the release of adrenocorticotropin from equine pituitary cells in vitro. Neuroendocrinology 65 64-69.
87. Navarre P, Tsagarakis S, Coy DH, Rees LH, Besser GM & Grossman AB 1990 Rat melanin concentrating hormone does not modify the release of CRH-41 from rat hypothalamus or ACTH from the anterior pituitary in vitro. Journal of Endocrinology 127 R1-R4.
88. Nicholson WE & Orth 1996 Prepro-thyrotropin-releasing hormone-(178-199) does not inhibit corticotropin release. Endocrinology 137 2171-2174.
89. Ono N, de Castro JCB & McCann SM 1985 Ultrashort-loop positive feedback of corticotropin (ACTH)-releasing factor to enhance ACTH release in stress. Proceedings of the National Academy of Sciences of the USA 82 3528-3531.
90. Page SR, Ang VT, Jackson R, White A, Nussey SS & Jenkins JS 1990 The effect of oxytocin infusion on adenohypophyseal function in man. Clinical Endocrinology 32 307-313.
91. Parkes DG & May CN 1995 ACTH-suppressive and vasodilator actions of adrenomedullin in conscious sheep. Journal of Neuroendocrinology 12 923-929.
92. Parkes D, Kasckow J & Vale W 1994 Carbon monoxide modulates secretion of corticotropin-releasing factor (CRF) from rat hypothalamic cell cultures. Brain Research 646 315-318.
93. Patchev VK, Montkowski A, Rouskova D, Koranyi L, Holsboer F & Almeida OF 1997 Neonatal treatment of rats with the neuroactive steroid tetrahydrodeoxycorticosterone (THDOC) abolishes the behavioural and neuroendocrine consequences of adverse early life events. Journal of Clinical Investigation 99 962-966.
94. Phlipponneau M, Nocaudie M, Epelbaum J, De Keyzer Y, Lalau JD, Marchandise X & Beragna X 1994 Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor. Journal of Clinical Endocrinology and Metabolism 78 20-24.
95. Pompeo A, Luini A, Hirata F, Baldassare M & Buccione R 1997 Neutrophil extracted lipocortin inhibits corticotropin secretion in the AtT-20 D16:16 clonal mouse pituitary cell line. Regulatory Peptide 72 169-177.
96. Pozzoli G, Mancuso C, Mirtella A, Preziosi P, Grossman AB & Navarra P 1994 Carbon monoxide as a novel neuroendocrine modulator: inhibition of stimulated corticotropin-releasing hormone release from acute rat hypothalamic explants. Endocrinology 135 2314-2317.
97. Raber J, Chen S, Mucke L & Feng L 1997 Corticotropin-releasing factor and adrenocorticotrophic hormone as potential central mediators of OB effects. Journal of Biological Chemistry 272 15057-15060.
98. Reddy DS & Kulkarni SK 1996 Role of GABA-A and mitochondrial diazepam binding inhibitor receptors in the anti-stress activity of neurosteroids in mice. Psychopharmacology 128 280-292.
99. Redei E, Hilderbrand H & Aird F 1995a Corticotropin release inhibiting factor is encoded within prepro-TRH. Endocrinology 136 1813-1816.
100. Redei E, Hilderbrand H & Aird F 1995b Corticotropin release-inhibiting factor is prepro-thyrotropin-releasing hormone-(178-199). Endocrinology 136 3557-3563.
101. Redei E, Rittenhouse PA, Revsky S, McGivern RF & Aird, F 1998 A novel endogenous corticotropin release inhibiting factor. Annals of the New York Academy of Sciences 840 456-469.
102. Rees LH, Cook DM, Kendall JW, Allen CF, Kramer RM, Ratcliffe JG & Knight RA 1971 A radioimmunoassay for rat plasma ACTH. Endocrinology 89 254-261.
103. Rivier C 1994 Endogenous nitric oxide participates in the activation of the hypothalamic-pituitary-adrenal axis by noxious stimulus. Endocrine Journal 2 367-373.
104. Rivier C 1995 Blockade of nitric oxide formation augments adrenocorticotropin released by blood-borne interleukin-1β: role of vasopressin, prostaglandins, and α1-adrenergic receptors. Endocrinology 136 3597-3603.
105. Rivier C 1998 Role of nitric oxide and carbon monoxide in modulating the ACTH response to immune and nonimmune signals. Neuroimmunomodulation 5 203-213.
106. Rivier C & Shen GH 1994 In the rat, endogenous nitric oxide modulates the response of the hypothalamic-pituitary-adrenal axis to interleukin-1 beta, vasopressin and oxytocin. Journal of Neuroscience 14 1985-1993.
107. Sakuma M, Yoshioka K, Suzuki H, Yanagisawa M, Onishi Y, Kobayashi N & Otsuka M 1991 Substance P-evoked release of GABA from isolated spinal cord ot the newborn rat. Neuroscience 45 323-330.
108. Samson WK 1998 Proadrenomedullin-derived peptides. Frontiers in Neuroendocrinology 19 100-127.
109. Samson WK, Murphy T & Schell DA 1995 A novel vasoactive peptide, adrenomedullin, inhibits pituitary adrenocorticotropin release. Endocrinology 136 2349-2352.
110. Sandi C & Guaza C 1995 Evidence for a role of nitric oxide in the corticotropin-releasing factor release induced by interleukin-1 beta. European Journal of Pharmacology 274 17-23.
111. Saphier D, Welch J, Farrar G, Nguyen N, Aguado F, Thaller T & Knight D 1994 Interactions between serotonin, thyrotropin-releasing hormone, and substance P in the CNS regulation of adrenocortical secretion. Psychoneuroendocrinology 19 779-797.
112. Sawchencko P, Swanson L & Joseph S 1982 The distribution and cells of origin of ACTH (1-39)-stained varicosities in the paraventricular and supraoptic nuclei. Brain Research 232 365-374.
113. Schwartz MW, Seeley RJ, Campfield LA, Burn P & Baskin DG 1996 Identification of targets of leptin action in rat hypothalamus. Journal of Clinical Investigation 98 1101-1106.
114. Shichiri M, Hirata Y, Kanno K, Ohta K, Emori T & Marumo F 1989 Effect of endothelin-1 on release of arginine vasopressin from perifused rat hypothalamus. Biochemical and Biophysical Research Communications 163 1332-1337.
115. Smith T, Flower RJ & Buckingham JC 1993 Lipocortins I, II and IV in the brain and the pituitary gland: selective induction by dexamethasone of lipocortin 1 in the anterior pituitary gland. Molecular Neuropharmacology 3 45-55.
116. Stalla GK, Brockmeier SJ, Renner U, Newton C, Buchfelder M, Stalla J & Muller OA 1994 Octreotide exerts different effects in vivo and in vitro in Cushing's disease. European Journal of Endocrinology 130 125-131.
117. Strijbos PJLM, Tilders FJH, Carey R, Forder R & Rothwell NJ 1991 Localization of immunoreactive lipocortin-1 in the brain and pituitary gland of the rat. Effects of adrenalectomy, dexamethasone and colchicine treatment. Brain Research 553 249-260.
118. Sudlow AW, Carey F, Forder R & Rothwell NJ 1996 Lipocortin-1 inhibits CRH stimulation of plasma ACTH and IL-1 beta-stimulated hypothalamic CRH release in rats. American Journal of Physiology 270 R54-R60.
119. Tan TT, Yang Z, Haung W & Lim AT 1994 ANF(1-28) is a potent suppressor of pro-opiomelanocortin (POMC) mRNA but a weak inhibitor of beta EP-li release from AtT-20 cells. Journal of Endocrinology 143 R1-R4.
120. Taylor A, Cowell A-M, Flower J & Buckingham JC 1993 Lipocortin-1 mediates an early inhibitory action of glucocorticoids on the secretion of ACTH by the rat anterior pituitary gland in vitro. Neuroendocrinology 58 430-439.
121. Tizabi Y & Calogero AE 1992 Effect of various neurotransmitters and neuropeptides on the release of corticotrophin-releasing hormone from the rat cortex in vitro. Synapse 10 341-348.
122. Torpy DJ, Grice JE, Hockings GI, Crosbie GV, Walters MM & Jackson RV 1995 Effect of sodium valproate on naloxone-stimulated ACTH and cortisol release in humans. Clinical and Experimental Pharmacology and Physiology 22 441-443.
123. Torpy DJ, Grice JE, Hockings GI, Walters MM, Crosbie GV & Jackson RV 1997 Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axis. Clinical and Experimental Pharmacology and Physiology 24 421-423.
124. Toufexis DJ, Thrivkraman KV, Plotsky PM, Morilak DA, Ning Huang N & Walker C-D 1998 Reduced noradrenergic tone to the hypothalamic paraventricular nucleus contributes to the stress hyporesponsiveness of lactation. Journal of Neuroendocrinology 10 417-427.
125. Tsagarakis S, Navarra P, Rees LH, Besser M & Grossman A 1989 Morphine directly modulates the release of stimulated corticotrophin-releasing factor-41 from rat hypothalamus in vitro. Endocrinology 124 2330-2335.
126. Tsagarakis S, Rees LH, Besser M & Grossman A 1990 Opiate receptor subtype regulation of CRF-41 release from rat hypothalamus in vitro. Neuroendocrinology 51 599-605.
127. Turnbull AV & Rivier C 1996 Corticotropin-releasing factor, vasopressin and prostaglandins mediate, and nitric oxide restrains, the hypothalamic-pituitary-adrenal response to acute local inflammation in the rat. Endocrinology 137 455-463.
128. Turnbull AV, Kim CK, Lee S & Rivier C 1999 Influence of carbon monoxide, and its interaction with nitric oxide, on the ACTH response of the normal rat to a physico-emotional stress. Journal of Neuroendocrinology 10 793-802.
129. Ur E, Faria M, Tsagarakis S, Anderson JV, Besser GM & Grossman A 1991 Atrial natriuretic peptide in physiological doses does not inhibit the ACTH or cortisol response to corticotrophin-releasing hormone-41 in normal human subjects. Journal of Endocrinology 131 163-167.
130. Vierhapper H 1996 Effect of endothelin-1 in man: impact on basal and stimulated concentrations of luteinizing hormone, follicle-stimulating hormone, thyrotropin, growth hormone, corticotropin, and prolactin with and without pretreatment with nifedipine. Metabolism 45 658-661.
131. Vierhapper H, Hollenstein U, Roden M & Nowotny P 1993 Effect of endothelin-1 in man: impact on basal and stimulated concentrations of luteinizing hormone, follicle-stimulating hormone, thyrotropin, growth hormone, corticotropin, and prolactin. Metabolism 42 902-906.
132. Vincent SR, Das S & Maines MD 1994 Brain heme oxygenase isoenzymes and nitric oxide synthase are co-localized in select neurons. Neuroscience 63 223-231.
133. Windle RJ, Shanks N, Lightman SL & Ingram CD 1997 Central oxytocin administration reduces stress-induced corticosterone release and anxiety behaviour in rats. Endocrinology 138 2829-2834.
134. Witorsch RJ & Brodish A 1972 Evidence for acute ACTH release by extrahypothalamic mechanisms. Endocrinology 90 1160-1167.
135. Wittert GA, Espiner EA, Richards AM, Donald RA, Livesey JH & Yandle TG 1993 Atrial natriuretic factor reduces vasopressin and angiotensin II but not the ACTH response to acute hypoglycaemic stress in normal men. Clinical Endocrinology 38 183-189.
136. Yamauchi N, Shibasaki T, Wakabayashi I & Demura H 1997 Brain beta-endorphin and other opioids are involved in stress-induced stimulation of the hypothalamic-pituitary-adrenal axis, the sympathetic nervous system, and the adrenal medulla in the rat. Brain Research 777 140-146.
137. Yasin SA, Costa A, Trainer P, Windle R, Forsling ML & Grossman A 1993a Nitric oxide modulates the release of vasopressin from rat hypothalamic explants. Endocrinology 133 1466-1469.
138. Yasin SA, Costa A, Besser GM, Hucks D, Grossman A & Forsling ML 1993b Melatonin and its analogs inhibit the basal and stimulated release of hypothalamic vasopressin and oxytocin in vitro. Endocrinology 132 1329-1336.
139. Yasin SA, Costa A, Navarra P, Pozzoli G, Kostoglou-Athanassiou I, Forsling ML & Grossman A 1994 Endothelin stimulates the in vitro release of neurohypophyseal hormones, but not corticotrophin-releasing hormone, via ETA receptors. Neuroendocrinology 60 553-558.